Yahoo Finance Live's Seana Smith breaks down the stocks trending in the after-hours trading session.
Pharvaris NV (NASDAQ: PHVS) announced topline data from the RAPIDe-1 Phase 2 study, demonstrating statistically significant results of PHVS416 as an oral on-demand treatment for hereditary angioedema (HAE) attacks. The study's primary endpoint is the change of a three-symptom composite (skin pain, skin swelling, abdominal pain) visual analog scale (VAS-3) score from pre-treatment to four hours post-treatment. Topline data from 147 attacks collected by 62 patients show that dose levels of PHVS416
Is it time to bet on a turnaround?
After falling for much of the week, the major stock market indexes were gaining ground early Thursday as investors digested the latest unemployment numbers. Last week's initial jobless claims suggest the Federal Reserve's campaign to combat inflation may finally be bearing fruit. Investors used that positive development as an excuse to buy up their favorite beaten-down tech stocks.
Have an issue with your financial adviser or looking to hire a new one? Email email@example.com.
The latest decision from ExxonMobil won't win any popularity contest, but it will make it a champion to its investors. On Thursday, the oil giant...
Retirement-eligible salaried employees at Ford were warned about retiring this year to maximize a lump sum pension payment.
At age 51, Anne Schieber was broke and disillusioned. She had worked for the IRS for 23 years and was regarded as one of the agency’s top auditors. But she never got promoted and never earned more than $3,150 in a year. With half her life already behind her, her retirement prospects looked bleak. But Schieber had learned a powerful secret from years of studying the tax returns of America’s richest residents. Over the next 50 years, it earned her a 449,000% return — making Schieber one of the mos
Investors searching for that feeling telling you market sentiment is shifting to a more positive outlook have been brought down to earth again. Following 2022’s market behavior to a tee, the recent rally has run into a brick wall. To wit, the S&P 500 notched 5 consecutive negative sessions over the last week with investors mulling over the prospect of a recession. Indeed, financial experts have been sounding the warning bells on the precarious state of the global economy. One of the doomsayers h
Shares of BioVie (NASDAQ: BIVI) were soaring 23.6% higher as of 11:19 a.m. ET on Thursday. The big jump appears to be the result of a delayed positive reaction by investors after the drugmaker reported results earlier this week from a phase 2 study evaluating experimental therapy NE3107. On Tuesday, BioVie's share price tumbled after the company's Monday evening announcement of results from its phase 2 study of NE3107 in treating Alzheimer's disease and Parkinson's disease.
Reconnaissance Energy Africa Ltd. (the "Company" or "ReconAfrica") (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) announces a conference call for investors and analysts will be held on Thursday, December 8, 2022 at 11:00 am Eastern Time. Participants will include Scot Evans, Chief Executive Officer, Dr. James Granath, Chief Geoscientist, and Grayson Andersen, Head of Capital Markets.
ARK ETF Founder Cathie Wood joins Yahoo Finance Live for a wide-ranging interview on the state of the crypto market, Elon Musk, Fed policy, Teladoc, and more.
The battery innovator is making progress on its lithium-metal batteries, but it still has a couple of years to go before it could start booking meaningful revenue.
Buy and hold forever? Not always.
Yahoo Finance's Jared Blikre highlights which stocks are making moves at the end of the trading session on Thursday.
L1 Capital International, an investment management company, released its “L1 Capital International Fund” third-quarter 2022 investor letter. A copy of the same can be downloaded here. The fund returned -0.4% net of fees in the third quarter compared to a 0.3% return for the MSCI World Net Total Return Index in AUD. The depreciation of Australian […]
In the latest trading session, Bank of America (BAC) closed at $32.44, marking a -0.92% move from the previous day.
In this article, we will be taking a look at the 22 most indebted companies in the world in 2022. To skip our detailed analysis, you can go directly to see 5 Most Indebted Companies in the World in 2022. When companies want to raise cash for their businesses, there are two main ways to […]
Shares of Cano Health (NYSE: CANO) were down as much as 35.6% this week and were still down 31.2% for the week as of late Thursday afternoon, according to data from S&P Global Intelligence. The stock fell even further after investment advisor Third Point, run by Dan Loeb, worried about Cano's liquidity, sold its remaining 3.5% stake in the company, according to a Bloomberg report. Cano, as of the third quarter, reported only $24 million in cash and cash equivalents.